TUMOR ABLATION MARKET ANALYSIS

Tumor Ablation Market, By Technology (Radiofrequency Ablation, Microwave Ablation, Cryo Ablation, Irreversible Electroporation, Laser Based Thermal Ablation, Other Ablation Technologies), By Treatment (Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation), By Application (Kidney Cancers, Liver Cancers, Breast Cancers, Lung Cancers, Prostate Cancers, Colorectal Cancers, Other Cancers), By Region (North America, Europem, Asia-Pacific, Middle East, Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Sep 2022
Code : CMI1270
Pages :152
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Tumor Ablation Market: Key Developments

In April 2021, Medtronic gains breakthrough appliances designation from the U.S. Food and Drug Administration for Emprint ablation catheter kit. This method assists the organization in reinforcing its product database.

In February 2017, Medtronic got Food and Drug Administration approval for OsteoCool RF ablation system. This system gained approval for palliative therapy of metastatic bone cancers.

In August 2020, Ethicon, a part of Johnson & Johnson, gained Food and Drug Administration breakthrough equipment title for microwave machinery. This plan helped the organization in improving its revenue generation.